Editorial
DOI:
https://doi.org/10.47924/neurotarget2009312Abstract
Dear colleagues, readers, friends:
It is very pleasing for NeuroTarget to complete its fourth year of life, periodically and uninterruptedly approaching the number of numbers planned since its inception. But we are particularly gratified by the acceptance we have observed from the Latin American medical community.
Metrics
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2009 Fabián Piedimonte
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.